These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 18514490)
1. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. Kingo K; Aunin E; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S J Dermatol Sci; 2008 Oct; 52(1):39-46. PubMed ID: 18514490 [TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis of melanocortin system in vitiligo. Kingo K; Aunin E; Karelson M; Philips MA; Rätsep R; Silm H; Vasar E; Soomets U; Kõks S J Dermatol Sci; 2007 Nov; 48(2):113-22. PubMed ID: 17651944 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274 [TBL] [Abstract][Full Text] [Related]
4. The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Reimann E; Kingo K; Karelson M; Reemann P; Loite U; Sulakatko H; Keermann M; Raud K; Abram K; Vasar E; Silm H; Kõks S Hum Immunol; 2012 Apr; 73(4):393-8. PubMed ID: 22333690 [TBL] [Abstract][Full Text] [Related]
6. Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. Rätsep R; Kingo K; Karelson M; Reimann E; Raud K; Silm H; Vasar E; Kõks S Br J Dermatol; 2008 Dec; 159(6):1275-81. PubMed ID: 18717682 [TBL] [Abstract][Full Text] [Related]
7. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Sravani PV; Babu NK; Gopal KV; Rao GR; Rao AR; Moorthy B; Rao TR Indian J Dermatol Venereol Leprol; 2009; 75(3):268-71. PubMed ID: 19439879 [TBL] [Abstract][Full Text] [Related]
8. Expression of human beta-defensins in patients with mycosis fungoides. Gambichler T; Skrygan M; Appelhans C; Tomi NS; Reinacher-Schick A; Altmeyer P; Kreuter A Arch Dermatol Res; 2007 Jul; 299(4):221-4. PubMed ID: 17415576 [TBL] [Abstract][Full Text] [Related]
9. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo. Norris A; Todd C; Graham A; Quinn AG; Thody AJ Br J Dermatol; 1996 Feb; 134(2):299-306. PubMed ID: 8746346 [TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis of the corticotrophin-releasing hormone-proopiomelanocortin system in psoriasis skin biopsies. Loite U; Kingo K; Reimann E; Reemann P; Vasar E; Silm H; Kõks S Acta Derm Venereol; 2013 Jul; 93(4):400-5. PubMed ID: 23303587 [TBL] [Abstract][Full Text] [Related]
11. Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera. Reimann E; Kingo K; Karelson M; Reemann P; Loite U; Keermann M; Abram K; Vasar E; Silm H; Kõks S Dermatology; 2012; 224(2):168-76. PubMed ID: 22572099 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of neuregulin1 in the lesional skin of vitiligo patients. Rani S; Kumari U; Bhardwaj S; Parsad D; Sharma VL; Kumar R Int J Dermatol; 2019 Feb; 58(2):242-249. PubMed ID: 30074619 [TBL] [Abstract][Full Text] [Related]
13. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153 [TBL] [Abstract][Full Text] [Related]
14. Assessment of gene expression levels of proopiomelanocortin (POMC) and melanocortin-1 receptor (MC1R) in vitiligo. Nagui NA; Mahmoud SB; Abdel Hay RM; Hassieb MM; Rashed LA Australas J Dermatol; 2017 May; 58(2):e36-e39. PubMed ID: 26437741 [TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets. Seif El Nasr H; Shaker OG; Fawzi MM; El-Hanafi G J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):103-8. PubMed ID: 22151832 [TBL] [Abstract][Full Text] [Related]
16. Cytokine mRNA expression in basal cell carcinoma. Gambichler T; Skrygan M; Hyun J; Bechara F; Tomi NS; Altmeyer P; Kreuter A Arch Dermatol Res; 2006 Aug; 298(3):139-41. PubMed ID: 16826314 [TBL] [Abstract][Full Text] [Related]
17. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo. Zailaie MZ Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818 [TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo. Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274 [TBL] [Abstract][Full Text] [Related]
19. Melanocytes are not absent in lesional skin of long duration vitiligo. Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216 [TBL] [Abstract][Full Text] [Related]
20. Preliminary evaluation of vitiligo using in vivo reflectance confocal microscopy. Ardigo M; Malizewsky I; Dell'anna ML; Berardesca E; Picardo M J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1344-50. PubMed ID: 17958840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]